Literature DB >> 14510588

Acylated preatroxigenin glycosides from Atroxima congolana.

Mohamed Elbandy1, Tomofumi Miyamoto, Clément Delaude, Marie-Aleth Lacaille-Dubois.   

Abstract

Six new acylated bisdesmosidic preatroxigenin saponins named atroximasaponins E1, E2 (1, 2), F1, F2 (3, 4), and G1, G2 (5, 6) were isolated as three inseparable mixtures of the trans- and cis-p-methoxycinnamoyl derivatives, from the roots of Atroxima congolana. Their structures were established through extensive NMR spectroscopic analysis as 3-O-beta-D-glucopyranosylpreatroxigenin-28-O-beta-D-xylopyranosyl-(1-->4)-alpha-L-rhamnopyranosyl-(1-->2)-[beta-D-glucopyranosyl-(1-->3)]-[4-O-trans-p-methoxycinnamoyl]-beta-D-fucopyranoside (atroximasaponin E1, 1), and its cis-isomer, atroximasaponin E2 (2), 3-O-beta-D-glucopyranosylpreatroxigenin-28-O-beta-D-xylopyranosyl-(1-->4)-alpha-L-rhamnopyranosyl-(1-->2)-[6-O-acetyl-beta-D-glucopyranosyl-(1-->3)]-[4-O-trans-p-methoxycinnamoyl]-beta-D-fucopyranoside (atroximasaponin F1, 3), and its cis-isomer, atroximasaponin F2 (4), 3-O-beta-D-glucopyranosylpreatroxigenin-28-O-beta-D-apiofuranosyl-(1-->3)-[alpha-l-rhamnopyranosyl-(1-->2)]-[4-O-trans-p-methoxycinnamoyl]-beta-D-fucopyranoside (atroximasaponin G1, 5), and its cis-isomer, atroximasaponin G2 (6), respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510588     DOI: 10.1021/np030057+

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Two new tryptophan derivatives from the seed kernels of Entada rheedei: effects on cell viability and HIV infectivity.

Authors:  L K Nzowa; R B Teponno; L A Tapondjou; L Verotta; Z Liao; D Graham; M-C Zink; L Barboni
Journal:  Fitoterapia       Date:  2013-03-26       Impact factor: 2.882

2.  Anti-Inflammatory Triterpene Glycosides from the Roots of Ilex dunniana Levl.

Authors:  Yu-Sheng Shi; Yan Zhang; Wen-Zhong Hu; Xi Chen; Xin Fu; Xia Lv; Li-Hong Zhang; Ning Zhang; Guang Li
Journal:  Molecules       Date:  2017-07-19       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.